Literature DB >> 6602296

T-cell conditioned media reverse T-cell unresponsiveness in lepromatous leprosy.

A Haregewoin, T Godal, A S Mustafa, A Belehu, T Yemaneberhan.   

Abstract

In some subjects the infective agent of leprosy, Mycobacterium leprae, causes disseminated (lepromatous) disease. Such subjects have a major role in the transmission of the disease and show deficient T-cell responses both in vivo and in vitro to M. leprae, but not to other antigens. Numerous studies have recently shown that T cells with functional capabilities after initial triggering with antigen can be maintained in a state of continuous proliferation in vitro when cultured in medium containing interleukin 2 (IL-2). Here we have studied the effect of IL-2 rich T-cell conditioned medium on lepromatous peripheral blood mononuclear cells. Our results show that although lepromatous T cells fail to produce IL-2 after exposure to M. leprae they can respond by proliferation to M. leprae in the presence of T-cell conditioned medium, suggesting that the unresponsiveness in lepromatous leprosy results from a deficiency in the production of IL-2 or related factors and not a lack of M. leprae-reactive T cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6602296     DOI: 10.1038/303342a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  53 in total

1.  Inhibition of apoptosis by ionomycin and zinc in peripheral blood mononuclear cells (PBMC) of leprosy patients.

Authors:  A Gupta; V K Sharma; H Vohra; N K Ganguly
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

2.  Lsr2 peptides of Mycobacterium leprae show hierarchical responses in lymphoproliferative assays, with selective recognition by patients with anergic lepromatous leprosy.

Authors:  Mehervani Chaduvula; A Murtaza; Namita Misra; N P Shankar Narayan; V Ramesh; H K Prasad; Rajni Rani; R K Chinnadurai; Indira Nath
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

3.  Enhancement of a delayed hypersensitivity reaction to a contact allergen, by the systemic administration of interleukin-2.

Authors:  Y Zaloom; L P Walsh; P McCulloch; G Gallagher
Journal:  Immunology       Date:  1991-04       Impact factor: 7.397

4.  Anti-L3T4 antibody treatment suppresses hepatic granuloma formation and abrogates antigen-induced interleukin-2 production in Schistosoma mansoni infection.

Authors:  R C Mathew; D L Boros
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

5.  A single cell assay for the study of gamma-interferon formation in leprosy patients.

Authors:  J Lindh; U Anderson; S Britton; M De Ley
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

6.  Strain differences in mouse cellular responses to Mycobacterium lepraemurium and BCG subcutaneous infections. I. Analysis of cell surface phenotype in local granulomas.

Authors:  F Roch; M A Bach
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

7.  Dissociation between interleukin-1 and interleukin-2 production in proliferative response to microbial antigens: restorative effect of exogenous interleukin-2.

Authors:  D Vismara; G Lombardi; E Piccolella; V Colizzi
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

8.  Influence of dose and route of Mycobacterium lepraemurium inoculation on the production of interleukin 1 and interleukin 2 in C57BL/6 mice.

Authors:  A Hoffenbach; P H Lagrange; M A Bach
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

9.  In vivo and in vitro administration of interleukin 2-containing preparation reverses T-cell unresponsiveness in Mycobacterium bovis BCG-infected mice.

Authors:  V Colizzi
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

10.  Influence of Mycobacterium leprae and its soluble products on the cutaneous responsiveness of leprosy patients to antigen and recombinant interleukin 2.

Authors:  G Kaplan; E P Sampaio; G P Walsh; R A Burkhardt; T T Fajardo; L S Guido; A de Miranda Machado; R V Cellona; R M Abalos; E N Sarno
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.